Vertex Pharmaceuticals (VRTX) Q4 Earnings and Revenues Top Estimates
VRTXVertex(VRTX) Zacks Investment Research·2024-02-06 07:21

Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of 4.20pershare,beatingtheZacksConsensusEstimateof4.20 per share, beating the Zacks Consensus Estimate of 4.10 per share. This compares to earnings of 3.76pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof2.443.76 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 2.44%. A quarter ago, it was expected that this drugmaker would post earnings of 3.92 per share when it actually produced earnings of $4.08, delivering a surprise of 4.08%. Over the last four quarters, the ...